Adaptive Biotechnologies Corp (ADPT) stock forecast · rev $142.4M
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
This ADPT forecast page states what the cached financials imply — not a price target and not a guarantee. Adaptive Biotechnologies Corp outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Period-over-period revenue change is not in cache for ADPT, so this page does not invent a growth rate.
ADPT currently screens at market cap $2.69B. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ADPT 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ADPT stock page.
Not investment advice.